We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.36%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$16.2B
AUM Growth
+$1.63B
Cap. Flow
+$893M
Cap. Flow %
5.51%
Top 10 Hldgs %
15.16%
Holding
2,286
New
215
Increased
1,251
Reduced
646
Closed
120

Sector Composition

Rank Sector Weight
1 Energy 9.92%
2 Technology 7.94%
3 Healthcare 7.8%
4 Financials 7.55%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFO
2076
DELISTED
Blackrock Florida Municipal 2020 Term Trust
BFO
$256K ﹤0.01%
16,595
-3,000
-15% -$45.9K
CDR
2077
DELISTED
Cedar Realty Trust, Inc
CDR
$255K ﹤0.01%
6,183
-4,667
-43% -$188K
CBF
2078
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
$255K ﹤0.01%
10,791
-325
-3% -$7.87K
VOC icon
2079
VOC Energy
VOC
$50.7M
$254K ﹤0.01%
14,875
-425
-3% -$6.48K
IIM icon
2080
Invesco Value Municipal Income Trust
IIM
$591M
$252K ﹤0.01%
16,820
-4,156
-20% -$62.4K
YDIV
2081
DELISTED
First Trust International Multi-Asset Diversified Income Index Fund
YDIV
$252K ﹤0.01%
+11,557
New +$247K
WCIC
2082
DELISTED
WCI Communities, Inc.
WCIC
$251K ﹤0.01%
+13,000
New +$250K
RGEN icon
2083
Repligen
RGEN
$9B
$250K ﹤0.01%
+10,986
New +$196K
OREX
2084
DELISTED
Orexigen Therapeutics, Inc.
OREX
$250K ﹤0.01%
4,050
-119
-3% -$6.92K
BANC icon
2085
Banc of California
BANC
$3.01B
$249K ﹤0.01%
+22,865
New +$261K
EWM icon
2086
iShares MSCI Malaysia ETF
EWM
$325M
$248K ﹤0.01%
3,906
-360
-8% -$22.9K
MYY icon
2087
ProShares Short MidCap400
MYY
$2.92M
$248K ﹤0.01%
+3,649
New +$259K
FEO
2088
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$247K ﹤0.01%
12,940
-1,278
-9% -$24K
TDAY
2089
USA Today Co
TDAY
$1.17B
$245K ﹤0.01%
+17,398
New +$248K
NQU
2090
DELISTED
NUVEEN QUALITY INCOME MUNI FD
NQU
$244K ﹤0.01%
17,800
-4,521
-20% -$61.7K
NAD icon
2091
Nuveen Quality Municipal Income Fund
NAD
$2.76B
$242K ﹤0.01%
17,080
-3,735
-18% -$51.8K
CENX icon
2092
Century Aluminum
CENX
$4.55B
$238K ﹤0.01%
+15,200
New +$215K
SWC
2093
DELISTED
Stillwater Mining Co
SWC
$238K ﹤0.01%
+13,551
New +$220K
TIBX
2094
DELISTED
TIBCO SOFTWARE INC
TIBX
$238K ﹤0.01%
+11,803
New +$235K
AU icon
2095
AngloGold Ashanti
AU
$44.3B
$237K ﹤0.01%
13,786
FSS icon
2096
Federal Signal
FSS
$7.8B
$233K ﹤0.01%
+15,905
New +$233K
NPP
2097
DELISTED
NUVEEN PERFORMANCE+MUN FUND
NPP
$233K ﹤0.01%
15,907
-1,819
-10% -$26.6K
PETS icon
2098
PetMed Express
PETS
$42.1M
$231K ﹤0.01%
+17,129
New +$226K
CCJ icon
2099
Cameco
CCJ
$40.8B
$229K ﹤0.01%
+11,665
New +$243K
JBLU icon
2100
JetBlue
JBLU
$2.34B
$229K ﹤0.01%
+21,099
New +$195K

Similar funds

Raymond James & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Raymond James & Associates held 2,286 positions worth $16.2B, up 11% from $14.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $893M of net new capital in Q2 2014, opening 215 new positions and adding to 1,251 existing holdings. Its largest new stake was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.

By sector, the portfolio is most concentrated in Energy at 9.9% of assets, up from 9.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was AstraZeneca, an estimated $38.6M trimmed.

  • Raymond James & Associates's largest Q2 2014 buy was Vanguard Total International Bond ETF: 174,739 shares worth $8.98M.
  • Raymond James & Associates added most to iShares MSCI EAFE ETF in Q2 2014, an estimated $38.2M increase.
  • Raymond James & Associates's biggest Q2 2014 reduction was AstraZeneca, cutting an estimated $38.6M.
  • Raymond James & Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $20.6M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $16.2B portfolio in Q2 2014.
  • Raymond James & Associates opened 215 new positions and closed 120 in Q2 2014.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $16.2B.

Based on Raymond James & Associates's 13F filing for Q2 2014, filed 13 Aug 2014.